4th- 6th April 2022 - TELOMERES and CANCER BIOLOGY conference

General Information

© dkfz.de

TELOMERES and CANCER BIOLOGY
conference

4th- 6th April 2022

 

  • FOCUS 1: BASIC TELOMERE BIOLOGY
  • FOCUS 2: COMPUTATIONAL TELOMERE ANALYSIS
  • FOCUS 3: CLINICAL TRANSLATION

 

The conference schedule will explicitly address time-zone differences to maximize international inclusiveness.

Confirmed Speakers

  • Roger Reddel (Children's Medical Research Institute)
  • Anabelle Decottignies (Université catholique de Louvain)
  • Rameen Beroukhim (Dana-Farber Cancer Institute/Harvard Medical School)
  • Aurélie Ernst (German Cancer Research Center)
  • Matthias Fischer (University Hospital Cologne)
  • Rachel Flynn (Boston University School of Medicine)
  • Stefan Fröhling (German Cancer Research Center)
  • Christopher Heaphy (Boston University School of Medicine)
  • Lilit Nersisyan (Armenian Bioinformatics Institute)
  • John Maciejowski (Memorial Sloan Kettering Cancer Center)
  • Priya Chudasama (German Cancer Research Center)
  • Adam Wahida (Technische Universität München)
  • Andrew Ludlow (University of Michigan)

Registration

Registration and "Call for Abstracts" will open at 1st of December 2021.

A link to a registration will be coming.

Description

The German Cancer Research Center (DKFZ) in Heidelberg will host a virtual conference on "Telomeres and Cancer Biology" on 4th-6th April 2022.
The interdisciplinary meeting will bring together basic biologists (FOCUS 1: BASIC TELOMERE BIOLOGY), computational scientists (FOCUS 2: COMPUTATIONAL TELOMERE ANALYSIS) and clinician scientists (FOCUS 3: CLINICAL TRANSLATION) to discuss recent discoveries in the field of replicative immortality and explore opportunities to translate them into improved patient health care.
The conference will cover the following specific research topics:

  • Novel experimental methods for telomere analysis of tumor samples and model systems
  • In silico analysis of telomeres from biomolecular data for diagnostic, prognostic and therapeutic purposes
  • The implementation of telomere biomarkers into precision oncology workflows
  • Advances in molecular targeting of telomere maintenance mechanisms
  • Cancer subtype-specific characterization of replicative immortality by multi-omics approaches
  • The impact of telomere crisis on genomic stability and cancer evolution

The conference schedule explicitly address time-zone differences to maximize international inclusiveness. For academic participants, the conference will be free of charge.

© dkfz.de

Board of Organizers

Hilda Pickett, PhD

Children's Medical Research Institute,

University of Sydney, Australia

 

Frank Westermann, MD

Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany

Division of Neuroblastoma Genomics, German Cancer Research Center (DKFZ), Heidelberg, Germany

 

Siyuan Zheng, PhD

Department of Health Population Sciences

Greehey Children's Cancer Research Institute

The University of Texas Health San Antonio, USA

 

Dennis Kappei, PhD

Cancer Science Institute of Singapore

National University of Singapore, Singapore

 

Lars Feuerbach, PhD

Comparative Cancer Genomics, Division of Applied Bioinformatics

German Cancer Research Center (DKFZ), Heidelberg, Germany

 

Administrative coordination:

Sabine Stainczyk, PhD

Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany

Division of Neuroblastoma Genomics, German Cancer Research Center (DKFZ), Heidelberg, Germany

 

IT-support:

Hans Bartelmeß, IT-Specialist

Division of Applied Bioinformatics / B330
Omics IT & Data Management Core Facility / W610

German Cancer Research Center (DKFZ), Heidelberg, Germany

nach oben
powered by webEdition CMS